Search by Drug Name or NDC
NDC 17478-0542-02 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is ADENOSINE.
Product Information
NDC | 17478-0542 |
---|---|
Product ID | 17478-542_f0e6a3b7-5974-47e8-96d3-cb2d2b0cd075 |
Associated GPIs | 35500010002015 |
GCN Sequence Number | 013630 |
GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
HIC3 | A2A |
HIC3 Description | ANTIARRHYTHMICS |
GCN | 35350 |
HICL Sequence Number | 003734 |
HICL Sequence Number Description | ADENOSINE |
Brand/Generic | Generic |
Proprietary Name | Adenosine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Adenosine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 3 |
Active Ingredient Units | mg/mL |
Substance Name | ADENOSINE |
Labeler Name | Akorn |
Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078076 |
Listing Certified Through | 2024-12-31 |
Package
NDC 17478-0542-02 (17478054202)
NDC Package Code | 17478-542-02 |
---|---|
Billing NDC | 17478054202 |
Package | 10 VIAL in 1 CARTON (17478-542-02) / 2 mL in 1 VIAL |
Marketing Start Date | 2011-03-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |